181 related articles for article (PubMed ID: 3024562)
1. Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir.
Larsson A; Stenberg K; Ericson AC; Haglund U; Yisak WA; Johansson NG; Oberg B; Datema R
Antimicrob Agents Chemother; 1986 Oct; 30(4):598-605. PubMed ID: 3024562
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
Abele G; Eriksson B; Harmenberg J; Wahren B
Antimicrob Agents Chemother; 1988 Aug; 32(8):1137-42. PubMed ID: 2847643
[TBL] [Abstract][Full Text] [Related]
3. Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine.
Ericson AC; Larsson A; Aoki FY; Yisak WA; Johansson NG; Oberg B; Datema R
Antimicrob Agents Chemother; 1985 May; 27(5):753-9. PubMed ID: 2990325
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R,S)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine, an anti-varicella-zoster virus drug.
Lake-Bakaar DM; Abele G; Lindborg B; Soike KF; Datema R
Antimicrob Agents Chemother; 1988 Dec; 32(12):1807-12. PubMed ID: 2854453
[TBL] [Abstract][Full Text] [Related]
5. Critical determinants of antiherpes efficacy of buciclovir and related acyclic guanosine analogs.
Datema R; Ericson AC; Field HJ; Larsson A; Stenberg K
Antiviral Res; 1987 Jul; 7(6):303-16. PubMed ID: 2823702
[TBL] [Abstract][Full Text] [Related]
6. Incorporation into nucleic acids of the antiherpes guanosine analog buciclovir, and effects on DNA and protein synthesis.
Stenberg K; Lundström M; Olofsson S; Datema R
Biochem Pharmacol; 1988 May; 37(10):1925-31. PubMed ID: 2837218
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
Stenberg K; Larsson A; Datema R
J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
[TBL] [Abstract][Full Text] [Related]
8. Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine.
Larsson A; Alenius S; Johansson NG; Oberg B
Antiviral Res; 1983 Aug; 3(2):77-86. PubMed ID: 6312878
[TBL] [Abstract][Full Text] [Related]
9. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.
Abele G; Karlström A; Harmenberg J; Shigeta S; Larsson A; Lindborg B; Wahren B
Antimicrob Agents Chemother; 1987 Jan; 31(1):76-80. PubMed ID: 3032092
[TBL] [Abstract][Full Text] [Related]
11. 9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication.
Larsson A; Oberg B; Alenius S; Hagberg CE; Johansson NG; Lindborg B; Stening G
Antimicrob Agents Chemother; 1983 May; 23(5):664-70. PubMed ID: 6307131
[TBL] [Abstract][Full Text] [Related]
12. Influence of acyclovir and bucyclovir on nucleotide pools in cells infected with herpes simplex virus type 1.
Karlsson AH; Harmenberg JG; Wahren BE
Antimicrob Agents Chemother; 1986 May; 29(5):821-4. PubMed ID: 3015006
[TBL] [Abstract][Full Text] [Related]
13. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the acyclic guanosine analog buciclovir [(R)-9-(3,4-dihydroxybutyl)guanine] in experimental genital herpes.
Lundgren B; Ericson AC; Berg M; Datema R
Antimicrob Agents Chemother; 1986 Feb; 29(2):294-7. PubMed ID: 3013082
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds.
Akesson-Johansson A; Harmenberg J; Wahren B; Linde A
Antimicrob Agents Chemother; 1990 Dec; 34(12):2417-9. PubMed ID: 1965107
[TBL] [Abstract][Full Text] [Related]
16. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
Larsson A; Sundqvist A; Parnerud AM
Mol Pharmacol; 1986 Jun; 29(6):614-21. PubMed ID: 3012321
[TBL] [Abstract][Full Text] [Related]
18. Improvement of the absorption of oral (R,S)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine, an anti-varicella-zoster virus drug, in rats and monkeys.
Lake-Bakaar DM; Lindborg B; Datema R
Antimicrob Agents Chemother; 1989 Jan; 33(1):110-2. PubMed ID: 2540706
[TBL] [Abstract][Full Text] [Related]
19. Acyclic guanosine analogs as inhibitors of human cytomegalovirus.
Wahren B; Larsson A; Rudén U; Sundqvist A; Sølver E
Antimicrob Agents Chemother; 1987 Feb; 31(2):317-20. PubMed ID: 3032096
[TBL] [Abstract][Full Text] [Related]
20. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals.
Boyd MR; Bacon TH; Sutton D
Antimicrob Agents Chemother; 1988 Mar; 32(3):358-63. PubMed ID: 3364954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
